## NVMI: Nova Ltd. - XLK: Technology

### Executive Summary

VALUE thesis: PEG 1.01 indicates fundamental undervaluation. Quality metrics strong (ROE 24%). Consistent execution (4/4 quarters beat estimates).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($309.30)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 124.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Tudor Investment Cor: 81.6% (+100.0%)
- FMR, LLC: 10.0% (+1.0%)
- Wasatch Advisors LP: 6.6% (-11.8%)
- Harel Insurance Inve: 4.9% (+6.4%)
- Migdal Insurance & F: 4.8% (-2.9%)

### Key Risks

1. High beta (1.84) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Volume divergence: price rising (+3.7% MRS) on declining volume (69% of avg) suggests distribution.
3. Market regime shift could impact high-beta names disproportionately.

### Catalysts

- Momentum building: MRS_20 improving +3.7% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.01 suggests fair value with growth premium. Forward P/E 35.0x stretched relative to 11% growth. Quality metrics strong (ROE 24%, margin 29%). Balance sheet: strong liquidity (4.6x). Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $10.0B |
| Beta | 1.84 |
| 52W Range | $154.00 - $361.32 |
| Short Interest | 4.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.01 |
| Forward P/E | 35.0 |
| Current P/E | 38.8 |
| YoY Growth | 10.8% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from 4.3% to 8.0% (+3.7% in 5 days), confirming momentum buildup. Currently in upper STRENGTH zone (4.0-10.0%), cross-sectional ranking at 91st percentile. MRS_5 at 2.6% confirms short-term momentum alignment. AM_20 at 10.3% shows strong absolute momentum above own 20MA. Outperforming sector by 6.8pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (4.91), confirming momentum.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 8.04% (CS: 92) | Strong |
| RSI_14 | 61.7 | Neutral |
| MACD Histogram | 4.91 | Bullish |
| vs SMA20 | 1.103x | Above |
| vs SMA50 | 1.052x | Above |
| vs SMA200 | 1.312x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $336.64
- **Stop Loss:** $309.30 (8.1% risk)
- **Target:** $391.32 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 43
- **Position Value:** $14,475.52
- **Portfolio %:** 14.48%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite. VIX remains in the mid-range, breadth is moderate, and yield curve is flat but not invertedâ€”indicating standard late-cycle conditions. Upbeat earnings and positive tech momentum are offset by cautious guidance in consumer sectors, suggesting selective positioning is favored.*

### Earnings

**Next:** 2026-02-12 (Est: $2.13)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.15 | $2.16 | +0.5% |
| 2025Q2 | $2.06 | $2.20 | +6.5% |
| 2025Q1 | $2.09 | $2.18 | +4.4% |
| 2024Q4 | $1.82 | $1.94 | +6.6% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*